Pricing Log in Create free account
Saturday 17 October 2026 Export COR’s income statement to Excel — free account

Cencora, Inc.

COR Healthcare Medical Distribution

Cencora, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $321.3 billion, up 9.31% from fiscal 2024. In the quarter to June 2026, revenue grew 5.07%, EPS grew 11.3%, free cash flow grew 3,385.3% and total debt rose 42.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years, revenue growth for ten; insiders bought in the last twelve months.

340.66 0.75 −0.22%
Market cap
$65.2B
P/E
25.2×
Fwd P/E
14.5×
Dividend yield
0.70%
F-score
6/9
Altman Z
4.83
Beneish M
−2.54
Dividend safety
74/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Cencora, Inc. (COR) Price to free cash flow

Alert me on Price to free cash flow

As of 16 October 2026, Cencora, Inc. (COR) trades at a price to free cash flow of 16.0×. Over the past ten years it has ranged from 0.0× (March 2025) to 52.4× (September 2025); the current reading is higher than 77% of that period. That is below the Healthcare sector median of 20.2×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 18.9× 26.72%
FY2024 14.9× 41.92%
FY2023 10.5× (17.85%)
FY2022 12.8× 15.82%
FY2021 11.0× 4.21%
FY2020 10.6× 24.59%
FY2019 8.5× (54.45%)
FY2018 18.7× 6.48%
FY2017 17.5× 177.52%
FY2016 6.3× 38.47%

Quarterly newest first

Period Price to free cash flow Change
Jun 2026 13.3× (65.11%)
Mar 2026 38.2× 112.30%
Dec 2025 18.0× (4.86%)
Sep 2025 18.9× (62.90%)
42 more quarters

Against its own ten years

Low 0.0× High 52.4×
Ten-year median 12.5×
Current reading's percentile 77

Price to free cash flow against peers

Company Price to free cash flow
HKPD Cellyan Biotechnology Co., Ltd compare n/m
ACH Accendra Health, Inc. compare n/m
FOCL FocalTherics compare n/m
AHG Akso Health Group Sponsored ADR compare n/m
COSM Cosmos Health Inc. compare n/m
CAH Cardinal Health, Inc. compare 13.2×
COR Cencora, Inc. 16.0×
HSIC Henry Schein, Inc. compare 17.2×
MCK McKesson Corporation compare 19.5×
Healthcare sector median 20.2×
Market median 14.2×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on COR